UK, attractive destination for Korean drug firms’ investment

Published: 2013-04-26 06:57:00

Updated: 2013-04-26 06:57:00

UK is one of the attractive countries where Korean drug companies can have an easier access for their investment, according to a global investment promotion agency.

In a local forum organized by the Korea Health Industry Development Institute on Wednesday, London Investment Agency CEO Seo You...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK